ArticleMolecular biology of the cell2026
Engineered interfaces in Rac1 and Cdc42 biosensors enhance sensitivity and reduce cell perturbation.
Article in Molecular biology of the cell, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Fluorescent biosensors are a valuable means to report the spatiotemporal dynamics of protein activities in live cells and animals. However, biosensors affect the activities they are reporting. This can be ameliorated by increasing sensitivity, using lower biosensor concentrations, or by choosing designs that minimize undesirable interactions. For biosensors in which fluorescent components interact to produce Forster Resonance Energy Transfer (FRET), perturbation is often due to interaction of biosensor components with nonfluorescent, endogenous proteins, rather than productive interactions that lead to FRET. Here, we engineer the interface between biosensor components using charge swap and "knob into hole" mutations to reduce all but desired interactions. Novel biosensors for Rac1 and Cdc42 showed reduced interactions with endogenous GTPases and effectors, normal activation by guanine nucleotide exchange factors (GEFs), and correctly reproduced previous reports of GTPase activation dynamics. Assaying concentration-dependent effects on cell motility showed substantially reduced perturbation of normal cell behavior. Computational models indicated that minimal perturbation could be achieved over a broader range of concentrations using the new "orthogonal" biosensors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.